Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania

BACKGROUND: The World Health Organization recommends regular therapeutic efficacy studies (TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy and safety of artemether-lumefantrine (AL) for the treatment of uncomplicated falciparum malaria were assessed through...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishengoma, Deus S., Mandara, Celine I., Francis, Filbert, Talundzic, Eldin, Lucchi, Naomi W., Ngasala, Billy, Kabanywanyi, Abdunoor M., Mahende, Muhidin K., Kamugisha, Erasmus, Kavishe, Reginald A., Muro, Florida, Mohamed, Ally, Mandike, Renata, Mkude, Sigsbert, Chacky, Frank, Paxton, Lynn, Greer, George, Kitojo, Chonge A., Njau, Ritha, Martin, Troy, Venkatesan, Meera, Warsame, Marian, Halsey, Eric S., Udhayakumar, Venkatachalam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427902/
https://www.ncbi.nlm.nih.gov/pubmed/30898164
http://dx.doi.org/10.1186/s12936-019-2730-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427902/
https://www.ncbi.nlm.nih.gov/pubmed/30898164
http://dx.doi.org/10.1186/s12936-019-2730-1

Ejemplares similares